Your Complete Mounjaro vs Wegovy Starter Comparison
Understanding Mounjaro vs Wegovy for Weight Loss: Starter Dose Differences
When comparing Mounjaro vs Wegovy for weight loss, the starter dose approach reveals key differences between these prescription-only medicines. Wegovy begins with a 0.25mg weekly injection for weeks 1-4, designed to help your body gradually adjust to semaglutide's appetite-suppressing effects. Mounjaro starts at 2.5mg weekly, reflecting tirzepatide's dual GIP and GLP-1 receptor mechanism that may require different initial dosing strategies. Both treatments require careful dose escalation over 16 weeks to reach their maintenance levels safely.
The choice between Mounjaro vs Wegovy for weight loss often depends on individual tolerance and medical history during these crucial first weeks. Wegovy's lower starting dose may suit patients concerned about initial side effects, whilst Mounjaro's dual-action approach targets both GIP and GLP-1 pathways from the beginning. Your prescriber will evaluate which starter approach aligns best with your weight management goals and medical profile when comparing these options.
Wegovy Starter Pricing: From £79.99 for Your First Month
Beginning your Mounjaro vs Wegovy for weight loss comparison, Wegovy's starter dose costs £79.99 for the 0.25mg pen covering weeks 1-4. New customers can apply discount code FIRST40 at checkout to secure this introductory pricing from our GPhC-registered pharmacy. For patients planning ahead, our Intro Duo bundle provides both starter (0.25mg) and second month (0.5mg) doses for £169.99, ensuring seamless progression through your initial treatment phase.
When evaluating Mounjaro vs Wegovy for weight loss costs, consider the complete 16-week escalation journey rather than just the starter dose. Our Intro Trio bundle (0.25mg, 0.5mg, 1mg) covers your first three months for £299.99, whilst returning customers benefit from code DOSE25 for ongoing treatment. This transparent pricing structure helps you budget effectively when choosing between these prescription weight management options.
Clinical Evidence: Comparing Mounjaro vs Wegovy for Weight Loss Effectiveness
Clinical trials demonstrate both treatments' effectiveness when comparing Mounjaro vs Wegovy for weight loss outcomes. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks (Wilding et al., NEJM, 2021). The SURMOUNT trials for Mounjaro showed patients may achieve significant weight reduction with tirzepatide's dual-action mechanism.
However, when comparing Mounjaro vs Wegovy for weight loss, it's important to note these trials used different methodologies and patient populations. Your individual response to either treatment will depend on various factors including adherence to the prescribed dose escalation schedule, dietary modifications, and increased physical activity alongside your chosen prescription-only medicine.
How Wegovy Works: Understanding the GLP-1 Mechanism
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormones to support weight management. This mechanism works by slowing gastric emptying, which helps you feel fuller for longer periods after eating smaller portions. The treatment also acts on brain appetite centres, potentially reducing food cravings and helping regulate eating behaviours. When comparing Mounjaro vs Wegovy for weight loss, Wegovy's single-pathway approach targets the well-established GLP-1 system that naturally responds to food intake. Clinical studies suggest this mechanism can support sustainable weight management when used alongside a reduced-calorie diet and increased physical activity. The once-weekly injection schedule helps maintain consistent hormone levels throughout your treatment journey.
Starting Your Treatment: EverydayMeds Clinical Assessment Process
Beginning treatment when comparing Mounjaro vs Wegovy for weight loss requires a thorough clinical assessment through our streamlined online process. Complete our 3-minute questionnaire covering your medical history, current medications, and weight management goals to help prescribers determine suitability. Our qualified prescribers review applications within 3 working days (express 24-hour service available), ensuring safe initiation of your chosen prescription-only medicine. Once approved, your starter dose ships via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity. This comprehensive process ensures you receive appropriate treatment whether choosing Wegovy's GLP-1 approach or exploring Mounjaro's dual-action mechanism. Our ongoing support continues throughout your dose escalation journey with expert guidance available whenever needed.
Storage and Practical Considerations for Wegovy Treatment
Proper storage plays a crucial role when comparing Mounjaro vs Wegovy for weight loss logistics, particularly for the starter dose phase. Wegovy requires refrigeration at 2-8°C before first use but offers exceptional travel flexibility with 6 weeks room temperature storage below 30°C once removed from the fridge. The FlexTouch pen design ensures accurate dosing throughout your 16-week escalation schedule, starting with the 0.25mg dose and progressing systematically to the 2.4mg maintenance level. This storage advantage over Mounjaro's 21-day room temperature limit makes Wegovy particularly suitable for patients with busy lifestyles or frequent travel commitments. The mandatory dose escalation cannot be skipped, ensuring your body adjusts safely to increasing semaglutide levels. Each pen delivers exactly four weekly doses, with clear markings to prevent dosing errors during your weight management journey.
First Month Expectations: Mounjaro vs Wegovy for Weight Loss Initial Response
During your first month, comparing Mounjaro vs Wegovy for weight loss reveals different initial experiences due to their distinct mechanisms. Wegovy's 0.25mg starter dose allows gradual introduction to GLP-1 effects, with many patients noticing reduced appetite and earlier satiety within the first two weeks. Some experience mild nausea initially, which typically improves as your body adjusts to the semaglutide. Managing these effects involves eating smaller portions, avoiding fatty foods, and staying well-hydrated throughout your starter phase.
When weighing Mounjaro vs Wegovy for weight loss expectations, remember that meaningful results develop progressively over months rather than weeks. The starter dose primarily focuses on tolerance building rather than maximum weight loss, preparing your system for higher therapeutic doses. Your prescriber will monitor progress and side effects before approving progression to the 0.5mg dose for weeks 5-8, ensuring safe advancement through your personalised treatment plan.
Making Your Decision: Expert Support for Mounjaro vs Wegovy for Weight Loss Choice
Choosing between Mounjaro vs Wegovy for weight loss ultimately depends on individual factors that our prescribers evaluate during your clinical assessment. Both treatments are available through EverydayMeds, with expert guidance helping determine which mechanism—Wegovy's GLP-1 approach or Mounjaro's dual GIP/GLP-1 action—aligns with your medical profile and treatment goals. Consider factors including your previous weight management attempts, current health conditions, lifestyle requirements, and tolerance for potential side effects. Our prescribers provide personalised recommendations based on clinical evidence and your individual circumstances rather than promoting one option over another. Start your comparison journey today with confidence, knowing that professional support guides every step of your treatment decision. Apply code FIRST40 as a new customer or DOSE25 for returning patients when ordering your chosen starter dose at https://everydaymeds.co.uk/products/wegovy-0-25mg, backed by our GPhC-registered pharmacy services (#9012878) and commitment to your weight management success.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
